PLoS One 11 , e0146505 (2016)
GLP-1associated weight loss may increase eating disorder vulnerability, medical instability, and poorer recovery outcomes, regardless of body size or BMI
In this study, 64 women with stage II and III breast cancer were divided into two groups: the control group (n = 32) received 4 cycles of doxorubicin plus cyclophosphamide (every 21 days) followed by weekly doses of paclitaxel for 12 weeks plus placebo tablets once daily
To gain a deeper understanding of the mechanism involved in the loss of cAMP generation observed in the triple AA phospho-null mutant receptor, we repeated the cAMP assays in INS-1 832/3 GLP-1R KO cells expressing WT or triple AA mutant receptors pre-treated with the PDE4-specific inhibitor rolipram (21)
Aim for a palm-sized portion of protein at every meal
We will continue to refine our analytical assays, because we know that things can happen at scale-up. Adaptations to the Process and Scale-up Speaking of scale-up, the panelists agreed that scale-up was less of a concern when it came to supply now than in years past